Functional responses and in vivo anti-tumour activity of h7C10: A humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors
Open Access
- 1 May 2007
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (8), 1318-1327
- https://doi.org/10.1016/j.ejca.2007.03.009
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor actionTrends in Endocrinology & Metabolism, 2006
- Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancerDrug Discovery Today, 2005
- Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibodyMolecular Cancer Therapeutics, 2005
- Role of insulin-like growth factor 1 receptor signalling in cancerBritish Journal of Cancer, 2005
- A recombinant humanized anti‐insulin‐like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti‐epidermal growth factor receptor therapy against human cancer xenograftsInternational Journal of Cancer, 2004
- In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinaseCancer Cell, 2004
- Inhibition of the Biologic Response to Insulin-like Growth Factor I in MCF-7 Breast Cancer Cells by a New Monoclonal Antibody to the Insulin-like Growth Factor-I Receptor. The Importance of Receptor Down-regulationHormone and Metabolic Research, 2003
- Results of a Pilot Study Involving the Use of an Antisense Oligodeoxynucleotide Directed Against the Insulin-Like Growth Factor Type I Receptor in Malignant AstrocytomasJournal of Clinical Oncology, 2001
- Specific Inhibition of Insulin-Like Growth Factor-1 and Insulin Receptor Tyrosine Kinase Activity and Biological Function by TyrphostinsEndocrinology, 1997
- Two New Monoclonal Antibodies against the α Subunit of the Human Insulin-like Growth Factor-I ReceptorBiochemical and Biophysical Research Communications, 1993